Cargando…
Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer
Primary and metastatic lung cancer is a leading cause of cancer-related death and novel therapies are urgently needed. Epidermal growth factor receptor (EGFR) and death receptor (DR) 4/5 are both highly expressed in primary and metastatic non-small cell lung cancer (NSCLC); however, targeting these...
Autores principales: | Moleirinho, Susana, Kitamura, Yohei, Borges, Paulo S G N, Auduong, Sophia, Kilic, Seyda, Deng, David, Kanaya, Nobuhiko, Kozono, David, Zhou, Jing, Gray, Jeffrey J, Revai-Lechtich, Esther, Zhu, Yanni, Shah, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346421/ https://www.ncbi.nlm.nih.gov/pubmed/37311043 http://dx.doi.org/10.1093/stcltm/szad033 |
Ejemplares similares
-
Cross‐matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting
por: Rowland, Aileen L., et al.
Publicado: (2020) -
Correction of T-Cell Repertoire and Autoimmune Diabetes in NOD Mice by Non-myeloablative T-Cell Depleted Allogeneic HSCT
por: Sidlik Muskatel, Rakefet, et al.
Publicado: (2023) -
Concise Review: Boosting T‐Cell Reconstitution Following Allogeneic Transplantation—Current Concepts and Future Perspectives
por: Simons, Laura, et al.
Publicado: (2019) -
A Pilot Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates With Hypoxic-Ischemic Encephalopathy
por: Cotten, Charles Michael, et al.
Publicado: (2023) -
Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
por: Cao, Zhouli, et al.
Publicado: (2023)